Skye Bioscience, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing a pending transaction with Redx, the planned termination of its CBeyond clinical trial, a material weakness in internal controls, and going concern risk.
Santander Holdings USA, Inc. filed a Current Report on November 13, 2026, recasting three years of consolidated financial statements to reflect a segment reporting change that combined its Commercial & Industrial and Commercial Real Estate reportable segments into a single Commercial Banking segment.
An amended beneficial ownership statement covering SilverBox Corp IV Class A Ordinary Shares was filed on November 13, 2026, by Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min (Joe) Wong, disclosing that each reporting person held 0 shares as of …
Winvest Acquisition Corp. filed a Form 8-K on November 13, 2026, disclosing the mutual termination of its Amended and Restated Business Combination Agreement with Embed Financial Group Holdings and related parties, effective November 9, 2026, and reporting a third $30,000 drawdown under a promissory …
Nantahala Capital Partners Limited Partnership filed an amended beneficial ownership statement with the SEC on November 13, 2026, reporting a 4.328% stake in Curis, Inc. (NASDAQ:CRIS) as of September 30, 2026.
Eric L. Oliver, a director and 10% owner of San Juan Basin Royalty Trust (NYSE:SJT), filed a Form 4 on November 13, 2026, disclosing purchases of units and call options in SJT by SoftVest, LP across November 11 and 12, 2026.
Curis, Inc. filed a Form S-8 registration statement with the SEC on November 13, 2026, registering 320,369 shares of common stock available for issuance under its 2026 Incentive Plan.
Curis, Inc. filed a Post-Effective Amendment No. 1 to fourteen previously effective Form S-8 registration statements on November 13, 2026, to reflect the transition of available share issuances from the company's 2010 Stock Incentive Plan and inducement award grants to its newly stockholder-approved 2026 …
Curis, Inc. filed a Post-Effective Amendment No. 1 to fourteen previously filed Form S-8 registration statements on November 13, 2026, redirecting up to 173,744 shares of common stock from the company's prior equity plans to its newly approved 2026 Incentive Plan.
Curis, Inc. filed a Post-Effective Amendment No. 1 to fourteen previously filed Form S-8 registration statements on November 13, 2026, redirecting 173,744 shares of common stock from the company's legacy 2010 Stock Incentive Plan and inducement award grants to its newly stockholder-approved 2026 Incentive …